Posts

Accurate Quantification and Characterization of Adeno-Associated Viral Vectors

on
0

Mitigation strategy for Unwanted Immunogenicity of Therapeutic Proteins

on
0

Taking immunogenicity assessment of therapeutic proteins to the next level

on
0

Immunogenicity of biotherapeutics for biosimilars and biobetters.

on
0

Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility.

on
0

Characterization of immunogenicity response to multiple domain biotherapeutics

on
0

Recommendation for risk-based bioanalytical strategy for the immunogenicity assessment for biologics

on
0

Antisense Oligonucleotide Volanesoren lowers triglyceride levels in Familial Chylomicronemia Syndrome

on
0

Correlation of anti-AAV9 Preexisting antibody with In Vivo Transduction and NAGLU activity

on
0

Nonclinical Non-human Primate Studies for Hemophilia investigate impact of preexisting antibodies against AAV5 on therapeutic efficacy

on
0

Industry trends on use of surrogate biomaker as endpoint for clinical benefit

on
0

GIVLAARI (givosiran, siRNA) for treatment of Acute Hepatic Porphyria

on
0

MALS (Multi Angle Stable Light Scattering)

on
0

Analytical Platform Review: Mass Spectrometers (LC-MS) for Protein Characterization and Quantification

on
1

Digital Droplet PCR (ddPCR) For Viral Vectors Biodistribution Studies For Gene Therapy

on
0

FDA raise concern over data manipulation for Zogensma (Gene therapy for SMA)

on
0

Engineering Immunodominant Residues of Cas9 reduces Cell Mediated Cytotoxicity

on
0

AAV-CRISPR mediated gene editing corrects Duchene Muscular Dystrophy phenotype

on
0

AVV5 mediated microRNA delivery for treatment of ALS

on
0

Pre-existing Immune Responses against Cas9 protein (CRISPR) add complexity to CRISPR based Gene Therapy

on
0